in order to evaluate the delay cropping on yield and yield component of two canola cultivars and selecting the best genotype and row spacing, an experiment was conducted at three years (2007, 2008 and 2009) in gorgan research station. this experiment was arranged in spilt-factorial based on randomized complete block design with four sowing dates (28 oct., 12 and 28 nov. and 12 dec.) as main plo...

Run-time monitors ensure that untrusted software and system behavior adheres to a security policy. This paper defines an expressive formal framework, based on I/O automata, for modeling systems, policies, and run-time monitors in more detail than is typical. We explicitly model, for example, the environment, applications, and the interaction between them and monitors. The fidelity afforded by t...

arginine (arg) requirements of male broilers (ross 308) reared at high altitude (2100 mabove sea level) during the 1-to 3-week period was estimated in a graded supplementationmethod, in which six diets (230 g kg-1 cp and 3200 kcal me kg-1) with arg increments of1.25 g kg-1 were applied to four pens of fifteen birds each. dietary arg content of theexperimental groups ranged from 10 g kg-1 (80% o...

PURPOSE To assess the efficacy of dodecafluoropentane emulsion (DDFPe), a nanodroplet emulsion with significant oxygen transport potential, in decreasing infarct volume in an insoluble-emboli rabbit stroke model. MATERIALS AND METHODS New Zealand White rabbits (N = 64; weight, 5.1 ± 0.50 kg) underwent angiography and received embolic spheres in occluded internal carotid artery branches. Rabbi...

BACKGROUND 3-hydroxy-3-methyl-glutaryl coenzyme A (HMG-CoA) reductase inhibitors have several pleiotropic effects, including anti-inflammatory properties, and are reported to improve endothelial functions. Pathophysiologically, acute lung injury (ALI) is caused by a severe inflammatory response and endothelial dysfunction. OBJECTIVE To investigate the effects of simvastatin (an HMG-CoA reduct...

The management of acute myeloid leukaemia (AML) in India remains a challenge. In a two-year prospective study at our centre there were 380 newly diagnosed AML (excluding acute promyelocytic leukaemia, AML-M3) patients. The median age of newly diagnosed patients was 40 years (range: 1-79; 12.3% were ≤ 15 years, 16.3% were ≥ 60 years old) and there were 244 (64.2%) males. The median duration of s...